216 related articles for article (PubMed ID: 29505168)
1. Evaluating oseltamivir prescriptions in Centers for Medicare and Medicaid Services medical claims records as an indicator of seasonal influenza in the United States.
Dahlgren FS; Shay DK; Izurieta HS; Forshee RA; Wernecke M; Chillarige Y; Lu Y; Kelman JA; Reed C
Influenza Other Respir Viruses; 2018 Jul; 12(4):465-474. PubMed ID: 29505168
[TBL] [Abstract][Full Text] [Related]
2. Patterns of seasonal influenza activity in U.S. core-based statistical areas, described using prescriptions of oseltamivir in Medicare claims data.
Dahlgren FS; Shay DK; Izurieta HS; Forshee RA; Wernecke M; Chillarige Y; Lu Y; Kelman JA; Reed C
Epidemics; 2019 Mar; 26():23-31. PubMed ID: 30249390
[TBL] [Abstract][Full Text] [Related]
3. Outpatient influenza antivirals in a distributed data network for influenza surveillance.
Cocoros NM; Panucci G; Haug N; Maher C; Reichman M; Toh S
Influenza Other Respir Viruses; 2018 Nov; 12(6):804-807. PubMed ID: 30053342
[TBL] [Abstract][Full Text] [Related]
4. Influenza Antiviral Expenditures and Outpatient Prescriptions in the United States, 2003-2012.
Suda KJ; Hunkler RJ; Matusiak LM; Schumock GT
Pharmacotherapy; 2015 Nov; 35(11):991-7. PubMed ID: 26598091
[TBL] [Abstract][Full Text] [Related]
5. Incidence of neuropsychiatric adverse events in influenza patients treated with oseltamivir or no antiviral treatment.
Smith JR; Sacks S
Int J Clin Pract; 2009 Apr; 63(4):596-605. PubMed ID: 19335705
[TBL] [Abstract][Full Text] [Related]
6. Statin Use and Risks of Influenza-Related Outcomes Among Older Adults Receiving Standard-Dose or High-Dose Influenza Vaccines Through Medicare During 2010-2015.
Izurieta HS; Chillarige Y; Kelman JA; Forshee R; Qiang Y; Wernecke M; Ferdinands JM; Lu Y; Wei Y; Xu W; Lu M; Fry A; Pratt D; Shay DK
Clin Infect Dis; 2018 Jul; 67(3):378-387. PubMed ID: 29438483
[TBL] [Abstract][Full Text] [Related]
7. Bleeding events following concurrent use of warfarin and oseltamivir by Medicare beneficiaries.
Mosholder AD; Racoosin JA; Young S; Wernecke M; Shoaibi A; MaCurdy TE; Worrall C; Kelman JA
Ann Pharmacother; 2013 Nov; 47(11):1420-8. PubMed ID: 24285759
[TBL] [Abstract][Full Text] [Related]
8. Effects of antiviral treatment on influenza-related complications over four influenza seasons: 2006-2010.
Spagnuolo PJ; Zhang M; Xu Y; Han J; Liu S; Liu J; Lichtveld M; Shi L
Curr Med Res Opin; 2016 Aug; 32(8):1399-407. PubMed ID: 27052817
[TBL] [Abstract][Full Text] [Related]
9. Antiviral treatment of patients with oseltamivir-resistant and oseltamivir-susceptible seasonal Influenza A (H1N1) infection during the 2007-2008 influenza season in the United States.
Dharan NJ; Gubareva LV; Klimov AI; Fiore AE; Bresee JS; Fry AM
Clin Infect Dis; 2010 Feb; 50(4):621-2. PubMed ID: 20095841
[No Abstract] [Full Text] [Related]
10. Trends in Outpatient Influenza Antiviral Use Among Children and Adolescents in the United States.
Antoon JW; Sarker J; Abdelaziz A; Lien PW; Williams DJ; Lee TA; Grijalva CG
Pediatrics; 2023 Dec; 152(6):. PubMed ID: 37953658
[TBL] [Abstract][Full Text] [Related]
11. Infections with oseltamivir-resistant influenza A(H1N1) virus in the United States.
Dharan NJ; Gubareva LV; Meyer JJ; Okomo-Adhiambo M; McClinton RC; Marshall SA; St George K; Epperson S; Brammer L; Klimov AI; Bresee JS; Fry AM;
JAMA; 2009 Mar; 301(10):1034-41. PubMed ID: 19255110
[TBL] [Abstract][Full Text] [Related]
12. Treatment with oseltamivir in children hospitalized with community-acquired, laboratory-confirmed influenza: review of five seasons and evaluation of an electronic reminder.
Wilkes JJ; Zaoutis TE; Keren R; Desai B; Leckerman KH; Hodinka RL; Metjian TA; Coffin SE
J Hosp Med; 2009 Mar; 4(3):171-8. PubMed ID: 19301375
[TBL] [Abstract][Full Text] [Related]
13. Use of oseltamivir after influenza infection is associated with reduced incidence of recurrent adverse cardiovascular outcomes among military health system beneficiaries with prior cardiovascular diseases.
Casscells SW; Granger E; Kress AM; Linton A; Madjid M; Cottrell L
Circ Cardiovasc Qual Outcomes; 2009 Mar; 2(2):108-15. PubMed ID: 20031822
[TBL] [Abstract][Full Text] [Related]
14. Demonstrating the use of high-volume electronic medical claims data to monitor local and regional influenza activity in the US.
Viboud C; Charu V; Olson D; Ballesteros S; Gog J; Khan F; Grenfell B; Simonsen L
PLoS One; 2014; 9(7):e102429. PubMed ID: 25072598
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the use of oseltamivir prophylaxis in the control of influenza outbreaks in long-term care facilities in Alberta, Canada: a retrospective provincial database analysis.
Ye M; Jacobs A; Khan MN; Jaipaul J; Oda J; Johnson M; Doroshenko A
BMJ Open; 2016 Jul; 6(7):e011686. PubMed ID: 27381211
[TBL] [Abstract][Full Text] [Related]
16. Influenza antiviral prescribing practices during the 2007-08 and 2008-09 influenza seasons in the setting of increased resistance to oseltamivir among circulating influenza viruses.
Dharan NJ; Beekmann SE; Fiore A; Finelli L; Uyeki TM; Polgreen PM; Fry AM
Antiviral Res; 2010 Nov; 88(2):182-6. PubMed ID: 20739002
[TBL] [Abstract][Full Text] [Related]
17. Increased Antiviral Treatment Among Hospitalized Children and Adults With Laboratory-Confirmed Influenza, 2010-2015.
Appiah GD; Chaves SS; Kirley PD; Miller L; Meek J; Anderson E; Oni O; Ryan P; Eckel S; Lynfield R; Bargsten M; Zansky SM; Bennett N; Lung K; McDonald-Hamm C; Thomas A; Brady D; Lindegren ML; Schaffner W; Hill M; Garg S; Fry AM; Campbell AP
Clin Infect Dis; 2017 Feb; 64(3):364-367. PubMed ID: 28013261
[TBL] [Abstract][Full Text] [Related]
18. The Relationship Between Oseltamivir and Suicide in Pediatric Patients.
Harrington R; Adimadhyam S; Lee TA; Schumock GT; Antoon JW
Ann Fam Med; 2018 Mar; 16(2):145-148. PubMed ID: 29531106
[TBL] [Abstract][Full Text] [Related]
19. Comparative effectiveness of high-dose versus standard-dose influenza vaccines in US residents aged 65 years and older from 2012 to 2013 using Medicare data: a retrospective cohort analysis.
Izurieta HS; Thadani N; Shay DK; Lu Y; Maurer A; Foppa IM; Franks R; Pratt D; Forshee RA; MaCurdy T; Worrall C; Howery AE; Kelman J
Lancet Infect Dis; 2015 Mar; 15(3):293-300. PubMed ID: 25672568
[TBL] [Abstract][Full Text] [Related]
20. Monitoring the fitness of antiviral-resistant influenza strains during an epidemic: a mathematical modelling study.
Leung K; Lipsitch M; Yuen KY; Wu JT
Lancet Infect Dis; 2017 Mar; 17(3):339-347. PubMed ID: 27914853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
